1-20 of 36
Altaf Mohammed
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Green Cancer Prevention and Beyond

Open Access
Sharon A. Ross, Nancy J. Emenaker, Amit Kumar, Gabriela Riscuta, Kajal Biswas, Shanker Gupta, Altaf Mohammed, Robert H. Shoemaker
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2024) 17 (3): 107–118.
https://doi.org/10.1158/1940-6207.CAPR-23-0308
Published: 04 March 2024
View articletitled, Green Cancer Prevention and Beyond
Open the PDF for Green Cancer Prevention and Beyond in another window
Journal Articles

Abstract P004: Targeting the RXR pathway for the prevention of triple-negative breast cancer

Free
Cassandra Moyer, Jamal Hill, Darian Coleman, Shizuko Sei, Altaf Mohammed, Martin Sanders, Powel Brown, Abhijit Mazumdar
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2023) 16 (1_Supplement): P004.
https://doi.org/10.1158/1940-6215.PrecPrev22-P004
Published: 01 January 2023
View articletitled, Abstract P004: Targeting the RXR pathway for the prevention of triple-negative breast cancer
Journal Articles

Abstract IA007: PREVENT agent development pipeline

Free
Mark Stevn Miller, Brian Cholewa, John Clifford, Vignesh Gunasekharan, Altaf Mohammed, Shanker Gupta, Robert Shoemaker, Shizuko Sei
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2022) 15 (12_Supplement_2): IA007.
https://doi.org/10.1158/1940-6215.TACPAD22-IA007
Published: 01 December 2022
View articletitled, Abstract IA007: PREVENT agent development pipeline
Journal Articles

Abstract A014: Targeting TAK1 for intercepting PanIN progression to ductal adenocarcinoma in an inducible KC mouse model

Free
Venkateshwar Madka, Gopal Pathuri, Gaurav Kuma, Anil Singh, Nicole Stratton, Courtney Houchen, Altaf Mohammed, Chinthalapally V. Rao
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2022) 15 (12_Supplement_2): A014.
https://doi.org/10.1158/1940-6215.TACPAD22-A014
Published: 01 December 2022
View articletitled, Abstract A014: Targeting TAK1 for intercepting PanIN progression to ductal adenocarcinoma in an inducible KC mouse model
Journal Articles

Abstract A005: Identification of lipid pharmacodynamic biomarkers in FAP model

Free
Ryan Beach, Altaf Mohammed, Daniel W. Rosenberg
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2022) 15 (12_Supplement_2): A005.
https://doi.org/10.1158/1940-6215.TACPAD22-A005
Published: 01 December 2022
View articletitled, Abstract A005: Identification of lipid pharmacodynamic biomarkers in FAP model
Journal Articles

Abstract IA013: Preclinical testing of CD73 inhibitors for pancreatic cancer immunoprevention

Free
Lincoln Ballew, Kanchan Singh, Vidhi Chandra, Tingting Mills, Erika Y. Faraoni, Victoria Mota, Trent Clark, Lana Vornik, Michelle I. Savage, Shizuko Sei, Altaf Mohammed, Holger K. Eltzschig, Powel H. Brown, Florencia McAllister, Jennifer M. Bailey-Lundberg
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2022) 15 (12_Supplement_2): IA013.
https://doi.org/10.1158/1940-6215.TACPAD22-IA013
Published: 01 December 2022
View articletitled, Abstract IA013: Preclinical testing of CD73 inhibitors for pancreatic cancer immunoprevention
Journal Articles

Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer

Open Access
Abhijit Mazumdar, William M. Tahaney, Jamal L. Hill, Yun Zhang, Sumankalai Ramachandran, Jitesh Kawedia, Jing Qian, Alejandro Contreras, Michelle I. Savage, Lana A. Vornik, Shizuko Sei, Altaf Mohammed, Powel H. Brown
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2022) 15 (12): 791–802.
https://doi.org/10.1158/1940-6207.CAPR-22-0106
Published: 01 December 2022
View articletitled, Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer
Open the PDF for Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract IA002: Combination of naproxen and a novel chemically-stable eicosapentaenoic acid analogue provide synergistic tumor protection in Pirc rats

Free
Ryan Beach, Yuichiro Hatano, Yong Qiao, James Grady, Shizuko Sei, Altaf Mohammed, Daniel W. Rosenberg
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2022) 15 (12_Supplement_2): IA002.
https://doi.org/10.1158/1940-6215.TACPAD22-IA002
Published: 01 December 2022
View articletitled, Abstract IA002: Combination of naproxen and a novel chemically-stable eicosapentaenoic acid analogue provide synergistic tumor protection in Pirc rats
Journal Articles

Targeting the Leukotriene Pathway for Colon Cancer Interception

Available to Purchase
Altaf Mohammed, Robert H. Shoemaker
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2022) 15 (10): 637–640.
https://doi.org/10.1158/1940-6207.CAPR-22-0331
Published: 04 October 2022
View articletitled, Targeting the Leukotriene Pathway for Colon Cancer Interception
Open the PDF for Targeting the Leukotriene Pathway for Colon Cancer Interception in another window
Journal Articles

Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat

Available to Purchase
Venkateshwar Madka, Gaurav Kumar, Gopal Pathuri, Janani Panneerselvam, Yuting Zhang, Vishal Ganta, Stanley Lightfoot, Ronald Lubet, Chen S. Suen, Vernon E. Steele, Naveena B. Janakiram, Altaf Mohammed, Chinthalapally V. Rao
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2021) 14 (11): 1009–1020.
https://doi.org/10.1158/1940-6207.CAPR-21-0057
Published: 01 November 2021
View articletitled, Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat
Open the PDF for Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat in another window
Includes: Supplementary data
Journal Articles

Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP)

Available to Purchase
Ahmet M. Ulusan, Praveen Rajendran, Wan Mohaiza Dashwood, Omer F. Yavuz, Sabeeta Kapoor, Trace A. Gustafson, Michelle I. Savage, Powel H. Brown, Shizuko Sei, Altaf Mohammed, Eduardo Vilar, Roderick H. Dashwood
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2021) 14 (3): 325–336.
https://doi.org/10.1158/1940-6207.CAPR-20-0262
Published: 02 March 2021
View articletitled, Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP)
Open the PDF for Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP) in another window
Includes: Supplementary data
Journal Articles

Cancer Immunoprevention: Challenges and Potential Opportunities for Use of Immune Checkpoint Inhibitors

Available to Purchase
Altaf Mohammed, Robert H. Shoemaker, Shizuko Sei
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2020) 13 (11): 897–900.
https://doi.org/10.1158/1940-6207.CAPR-20-0432
Published: 03 November 2020
View articletitled, Cancer Immunoprevention: Challenges and Potential Opportunities for Use of Immune Checkpoint Inhibitors
Open the PDF for Cancer Immunoprevention: Challenges and Potential Opportunities for Use of Immune Checkpoint Inhibitors in another window
Journal Articles

Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers

Available to Purchase
Altaf Mohammed, Mark Steven Miller, Ronald A. Lubet, Chen S. Suen, Shizuko Sei, Robert H. Shoemaker, Margaret M. Juliana, Fariba L. Moeinpour, Clinton J. Grubbs
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2020) 13 (3): 273–282.
https://doi.org/10.1158/1940-6207.CAPR-19-0339
Published: 04 March 2020
View articletitled, Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers
Open the PDF for Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers in another window
Includes: Supplementary data
Journal Articles

Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model

Available to Purchase
Venkateshwar Madka, Gaurav Kumar, Gopal Pathuri, Yuting Zhang, Stanley Lightfoot, Adam S. Asch, Altaf Mohammed, Vernon E. Steele, Chinthalapally V. Rao
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2020) 13 (2): 185–194.
https://doi.org/10.1158/1940-6207.CAPR-19-0265
Published: 05 February 2020
View articletitled, Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model
Open the PDF for Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model in another window
Includes: Supplementary data
Journal Articles

Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma

Free
Altaf Mohammed, Naveena B. Janakiram, Venkateshwar Madka, Yuting Zhang, Anil Singh, Laura Biddick, Qian Li, Stanley Lightfoot, Vernon E. Steele, Ronald A. Lubet, Chen S. Suen, Mark Steven Miller, Shizuko Sei, Chinthalapally V. Rao
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2019) 12 (11): 751–762.
https://doi.org/10.1158/1940-6207.CAPR-19-0312
Published: 01 November 2019
View articletitled, Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma
Open the PDF for Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma in another window
Includes: Supplementary data
Journal Articles

Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo

Free
Venkateshwar Madka, Altaf Mohammed, Qian Li, Yuting Zhang, Laura Biddick, Jagan M.R. Patlolla, Stan Lightfoot, Rheal A. Towner, Xue-Ru Wu, Vernon E. Steele, Levy Kopelovich, Chinthalapally V. Rao
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2016) 9 (1): 53–62.
https://doi.org/10.1158/1940-6207.CAPR-15-0199
Published: 06 January 2016
View articletitled, Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo
Open the PDF for Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo in another window
Includes: Supplementary data
Journal Articles

Improved Innate Immune Responses by Frondanol A5, a Sea Cucumber Extract, Prevent Intestinal Tumorigenesis

Free
Naveena B. Janakiram, Altaf Mohammed, Taylor Bryant, Stan Lightfoot, Peter D. Collin, Vernon E. Steele, Chinthalapally V. Rao
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2015) 8 (4): 327–337.
https://doi.org/10.1158/1940-6207.CAPR-14-0380
Published: 31 March 2015
View articletitled, Improved Innate Immune Responses by Frondanol A5, a Sea Cucumber Extract, Prevent Intestinal Tumorigenesis
Open the PDF for Improved Innate Immune Responses by Frondanol A5, a Sea Cucumber Extract, Prevent Intestinal Tumorigenesis in another window
Includes: Supplementary data
Journal Articles

Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating Ornithine Decarboxylase Signaling

Free
Altaf Mohammed, Naveena B. Janakiram, Venkateshwar Madka, Rebekah L. Ritchie, Misty Brewer, Laura Biddick, Jagan Mohan R. Patlolla, Michael Sadeghi, Stan Lightfoot, Vernon E. Steele, Chinthalapally V. Rao
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2014) 7 (12): 1198–1209.
https://doi.org/10.1158/1940-6207.CAPR-14-0176
Published: 01 December 2014
View articletitled, Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating Ornithine Decarboxylase Signaling
Open the PDF for Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating Ornithine Decarboxylase Signaling in another window
Includes: Supplementary data
Journal Articles

Abstract B55: Multitargeted low-dose combination chemoprevention: A novel, ideal, and promising approach to combat colon carcinogenesis

Free
Altaf Mohammed, Naveena Janakiram, Misty Ely, Steele E. Vernon, Chinthalapally V. Rao
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (12_Supplement): B55.
https://doi.org/10.1158/1940-6207.PREV-10-B55
Published: 24 October 2014
View articletitled, Abstract B55: Multitargeted low-dose combination chemoprevention: A novel, ideal, and promising approach to combat colon carcinogenesis
Journal Articles

Abstract A111: Endogenous conversion of n-6 PUFAs to n-3 PUFAs prevents progression of K-Ras activated pancreatic lesion development to pancreatic ductal carcinoma in Fat-1 transgenic mice

Free
Altaf Mohammed, Naveena B. Janakiram, Misty Brewer, Ashley Duff, Stan Lightfoot, Richard S. Brush, Robert E. Anderson, Chinthalapally V. Rao
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (10_Supplement): A111.
https://doi.org/10.1158/1940-6207.PREV-11-A111
Published: 23 October 2014
View articletitled, Abstract A111: Endogenous conversion of n-6 PUFAs to n-3 PUFAs prevents progression of K-Ras activated pancreatic lesion development to pancreatic ductal carcinoma in Fat-1 transgenic mice